Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

6505--Alendronate Tablets Effective 05/21/2026 - 05/20/2027

Awarded
36E79725R0069Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

This contract pertains to the procurement of Alendronate Tablets for the Department of Veterans Affairs, managed through the Nac Pharmaceuticals solicitation number 36E79725R0069. The acquisition involves a one-year base period with four optional one-year extensions, aiming to supply specified quantities of 35MG and 70MG tablets in various packaging configurations, including bottles and blister packs, with detailed packaging, labeling, and bar-coding requirements aligned with federal standards. The solicitation emphasizes compliance with FAR clauses, including those related to security, privacy, small business subcontracting, and anti-conflict provisions, with references to the USP-NF for pharmaceutical standards and federal specifications for packaging and labeling. Offerors are required to submit firm-fixed-price proposals, including a 0.5% Cost Recovery Fee, covering all line items across the base and option years, with evaluation based on lowest evaluated price among technically acceptable and responsible offers. The contract mandates strict delivery and inspection protocols, with products inspected and accepted at the Government’s destination, ensuring all pharmaceuticals are FDA-approved and manufactured under current Good Manufacturing Practices. Delivery is structured through the Prime Vendor system, with performance periods defined by an implementation window of up to 60 days post-award and subsequent ordering periods extending up to five years, including options. Proposal submissions must be made electronically via email, including a signed SF-1449, with no page limits specified, and must be received by the deadline of November 13, 2025. The contract incorporates extensive FAR and VAAR clauses covering ethics, security, subcontracting, and reporting requirements, and emphasizes the importance of accurate representations regarding small business status, socioeconomic categories, and compliance certifications. Overall, the contract emphasizes quality, compliance, and cost-effectiveness in supplying pharmaceuticals to support VA healthcare operations.

General Info

Contract Value

$0

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

IL, USA

Set-Aside

NONE

Award Issued Date

Documents

3

RFP 36E79725R0069 for Alendronate Tablets

DOCX, High priority: read this first2 pages · presolicitation
High

Solicitation 36E79725R0069 for VA Pharmaceutical Prime Vendor Alendronate Tablets

DOCX, High priority: read this first66 pages · rfq
High

Award 36E79726D0016 for Alendronate Tablets

DOCX, Low priorityaward
Low

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseAwarded
Posted

Presolicitation

Type Changed

Presolicitation → Solicitation

Awarded

Contract was awarded

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Veterans Affairs → Nac Pharmaceuticals (36E797)
Contacts1 person available
OfficeHINES, IL, 60141, USA
Office AddressHINES, IL, 60141, USA
Contacts
Michael OlszewskiMichael Olszewski

Full Description

Show more
Presolicitation Notice
Page 1 of
Presolicitation Notice
Page 1 of 3 Presolicitation Notice *=Required Field Presolicitation Notice
Page 4 of 4
DESCRIPTION Presolicitation Notice
Presolicitation Notice
Page 3 of 3 Page 1 of 4 Page 1 of 4 Presolicitation Notice *=Required Field Presolicitation Notice
Page 1 of 3 Page 1 of Page 1 of PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79725R0069 for an unrestrictive procurement for Alendronate Tablets for the Department of Veterans Affairs (VA), Bureau of Prisons (BOP), and Indian Health Service (IHS). The VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have a unique NDC/UPC number. The standard package is a blister pack, but VA will accept unit of use bottles. Solicitation #36E79725R0069 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about October 28, 2025, with a tentative closing date of November 13, 2025. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at the following URL: www.beta.sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check this URL for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Michael Olszewski. Questions can be e-mailed to: contact@example.gov. The estimated annual requirements are as follows:
ITEM
DESCRIPTION PACKAGE SIZE (BOTTLES/BLISTER PACKS) TOTAL ESTIMATED ANNUAL USAGE (BOTTLES/BLISTER PACKS) 1 ALENDRONATE 35MG TAB 4 21,300 2 ALENDRONATE 35MG TAB 12 5,354 3 ALENDRONATE 70MG TAB 4 80,074 4 ALENDRONATE 70MG TAB 12 100,609

Similar Contracts

Same NAICS industry code

NAICS: 325412
New
Federal
6505--766-27-1-400-0021 -Charleston CMOP CALCIUM 500MG/VIT D 500UNIT CHEW TAB 90CT -(VA-27-00014312)
Solicitation # 36C77027Q0013
The Department of Veterans Affairs National CMOP Office is conducting market research through a Sources Sought notice to identify qualified sources for Calcium 500mg/Vitamin D 500unit chewable tablets in 90-count packaging. This effort is for market research purposes only and does not constitute a solicitation or an obligation to issue a contract. Interested vendors must submit their company point of contact, SAM Unique Entity ID, and a capability statement via email to the contract specialist by October 29, 2026. The anticipated requirement involves a total quantity of 3,200 packages, delivered in monthly increments of 800 units over four months, with the first delivery due 10 days after receipt of order. Products must be sourced directly from the Original Equipment Manufacturer and possess an FDA therapeutic equivalence code of A, unless all drugs in the family group are B rated. Technical requirements include a distinct eleven-digit National Drug Code for each product, a minimum shelf life of 12 months from delivery, and specific bottle dimensions of at least 100cc with a 5.75-inch circumference and child-safety caps for packages under 500 count. Strict packaging and labeling standards apply, requiring bar codes that conform to GS1-128 or HIBCC/HIBC standards with a minimum ANSI/ISO/IEC Quality Grade C. Bar codes must be placed on both the outside wrapper and the immediate container. Shipping documentation must include the VA Purchase Order and Obligation numbers, and products must be sorted by lot number, with only one lot per box. Invoicing will be handled by the VA Fiscal Service Center, and the invoice price must strictly match the purchase order price to avoid payment delays.
National Cmop Office (36C770)

POSTED

1 day ago

DEADLINE

in 2 days
View Details

More opportunities from Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)

Same awarding agency

NAICS: 325412
New
Federal
6505--Sacubitril/Valsartan Tablets (VA-27-00014055)
Solicitation # 36E79727R0007
The Department of Veterans Affairs Enterprise Procurement Office intends to award a single, unrestricted national mandatory requirements contract for an uninterrupted source of supply of Sacubitril-Valsartan Tablets. This procurement, issued under NAICS code 325412 and FAR Part 12, supports multiple federal entities, including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers. The contract will span a one-year base period with four pre-priced one-year option periods. Distribution will be managed through the VA and DoD Pharmaceutical Prime Vendor Programs, requiring the contractor to execute necessary chargeback agreements to ensure timely delivery. The successful offeror must provide a unique eleven-digit National Drug Code (NDC) where the first five digits identify the offeror, and this must be the only label on the product. Strict packaging specifications are required for 60 and 180 count bottles, including a minimum volume of 120cc, a cylindrical body with at least a 5.75 inch circumference, and a safety cap that is either convertible or deshellable. Bottles must accommodate a 5.25 by 2 inch label with an additional 0.5 inch of space for barcodes and expiration data. Offerors who are not the manufacturer must provide a letter of commitment ensuring a sufficient source of supply. The solicitation is expected to be issued around December 18, 2026, with a tentative closing date of January 7, 2027.
Pharmaceutical Preparation Manufacturing

POSTED

5 days ago

DEADLINE

in 7 days
View Details
NAICS: 325412
Federal
6505--Imatinib Tablets
Solicitation # 36E79726R0036
The Department of Veterans Affairs is seeking an unrestricted procurement to establish a firm fixed price, indefinite-delivery requirements contract for Imatinib Mesylate Tablets in 100MG and 400MG strengths. This contract supports a wide range of federal entities, including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The award consists of a base year plus four pre-priced one-year option periods, with estimated annual quantities of 6,397 bottles for the 100MG tablets and 19,504 bottles for the 400MG tablets. Award will be based on the lowest evaluated price for proposals that meet all non-cost acceptability standards, including a review of past performance to determine contractor responsibility. Strict technical and regulatory requirements apply to this procurement. All products must be compatible with automated dispensing units and packaged in non-glass cylindrical bottles with specific dimensions and safety caps. Labeling must include a unique 11-digit NDC number and conform to GS1-128 or HIBCC HIBC bar-coding standards, as well as Drug Supply Chain Security Act (DSCSA) requirements for two-dimensional data matrix bar codes and serialized transaction information. Offerors must maintain an acceptable cGMP status with the FDA and provide an ANDA, NDA, or BLA. Proposals are due by October 30, 2026, and must be submitted in Word or PDF format via email.
Pharmaceutical Preparation Manufacturing

POSTED

11 days ago

DEADLINE

in 3 days
View Details

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS